Schizophrenia Clinic Group
|
principal investigator :
Miquel Bernardo
bernardo@clinic.ub.es
Department:
Unitat d'Esquizofrènia
Center:
Hospital Clinic de Barcelona
Institution:
Hospital Clinic de Barcelona, UB, IDIBAPS, CIBERSAM
Members: 6
Research lines:
Research line in schizophrenia focused on the following areas: physical health; genetics; neuroimaging; Neuropsychology, psychometric assessment and psychoeducation; neurobiology and neuropsychopharmacology population and high-risk, early-onset, first and second psychotic episodes.
Areas:
Central Nervous System Disorders
Glial cells
Cognition
Keywords:
Schizophrenia, Physical health, Genetics, Neuroimaging, Neuropsychology, Psychoeducation, neurobiology, neuropsychopharmacology, early onset, First episodes of psychosis.
Publications:
Bioque M, García-Bueno B, Mac-Dowell KS, Meseguer A, Saiz PA, Parellada M, González-Pinto A, Rodriguez-Jimenez R, Lobo A, Leza JC, Bernardo M.Peripheral endocannabinoid system dysregulation in first episodes of psychosis.Neuropsychopharmacology. 2013 Dec;38(13):2568-77.
doi: 10.1038/npp.2013.165.
Factor d'Impacte 2012= 8,678
Penades R, Pujol N, Catalán R, Masana G, Rametti G, García-Rizo C, argalló N, Gastó C, Bernardo M, Junqué C.Brain effects of cognitive remediation therapy in schizophrenia: a structural and functional neuroimaging study. Biol Psychiatry. 2013 May 15;73(10):1015-23
Factor d'Impacte 2012= 9,247
Batalla A, García-Rizo C, Castellví P, Fernández-Egea E, Yucel M, Parellada E, Kirkpatrick B, Martín-Santos R, Bernardo M. Screening for substance use disorders in first-episode psychosis: implication for readmission. Schizophrenia Res 2013;146:125-131
Factor d'Impacte 2012= 4,59
Notes:
Group Web site
|
|
|
